Cargando…

Hemophagocytic inflammatory syndrome in ADA-SCID: report of two cases and literature review

Hemophagocytic inflammatory syndrome (HIS) is a rare form of secondary hemophagocytic lymphohistiocytosis caused by an impaired equilibrium between natural killer and cytotoxic T-cell activity, evolving in hypercytokinemia and multiorgan failure. In the context of inborn errors of immunity, HIS occu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fratini, Elena Sophia, Migliavacca, Maddalena, Barzaghi, Federica, Fossati, Claudia, Giannelli, Stefania, Monti, Ilaria, Casiraghi, Miriam, Ferrua, Francesca, Recupero, Salvatore, Consiglieri, Giulia, Calbi, Valeria, Tucci, Francesca, Gallo, Vera, Bernardo, Maria Ester, Cenciarelli, Sabina, Palmoni, Monica, Moni, Margherita, Galimberti, Luca, Duse, Marzia, Leonardi, Lucia, Sieni, Elena, Soncini, Elena, Porta, Fulvio, Notarangelo, Lucia Dora, De Santis, Raffaella, Ladogana, Saverio, Aiuti, Alessandro, Cicalese, Maria Pia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331599/ https://www.ncbi.nlm.nih.gov/pubmed/37435083 http://dx.doi.org/10.3389/fimmu.2023.1187959

Ejemplares similares

Outcome of BCG Vaccination in ADA-SCID Patients: A 12-Patient Series
por: Canarutto, Daniele, et al.
Publicado: (2023)

Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis- related graft failure and disseminated bacillus Calmette-Guérin infection
por: Tucci, Francesca, et al.
Publicado: (2020)

Maternal T-cell engraftment impedes with diagnosis of a SCID-ADA patient
por: Lanfranchi, Arnalda, et al.
Publicado: (2018)

Wiskott–Aldrich syndrome: Oral findings and microbiota in children and review of the literature
por: Lucchese, Alessandra, et al.
Publicado: (2022)

A Case of Two Adult Brothers with Wiskott-Aldrich Syndrome, One Treated with Gene Therapy and One with HLA-Identical Hematopoietic Stem Cell Transplantation
por: Consiglieri, Giulia, et al.
Publicado: (2021)

Successful Treatment With Ledipasvir/Sofosbuvir in an Infant With Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency With HCV Allowed Gene Therapy with Strimvelis
por: Tucci, Francesca, et al.
Publicado: (2018)

Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case Report
por: Cenciarelli, Sabina, et al.
Publicado: (2020)

Peripheral blood stem and progenitor cell collection in pediatric candidates for ex vivo gene therapy: a 10-year series
por: Canarutto, Daniele, et al.
Publicado: (2021)

Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy
por: Tucci, Francesca, et al.
Publicado: (2019)

Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients
por: Sauer, Aisha V., et al.
Publicado: (2017)

Gene therapy in rare diseases: the benefits and challenges of developing a patient-centric registry for Strimvelis in ADA-SCID
por: Stirnadel-Farrant, Heide, et al.
Publicado: (2018)

Third cranial nerve palsy in an 88-year-old man after SARS-CoV-2 mRNA vaccination: change of injection site and type of vaccine resulted in an uneventful second dose with humoral immune response
por: Cicalese, Maria Pia, et al.
Publicado: (2022)

First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature
por: Migliavacca, Maddalena, et al.
Publicado: (2018)

Gene therapy for ADA‐SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products
por: Aiuti, Alessandro, et al.
Publicado: (2017)

A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease
por: Migliavacca, Maddalena, et al.
Publicado: (2022)

Use of Defibrotide to help prevent post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic stem cell gene therapy
por: Calbi, Valeria, et al.
Publicado: (2018)

Evaluation of clonal hematopoiesis in pediatric ADA-SCID gene therapy participants
por: White, Shanna L., et al.
Publicado: (2022)

Nonconditioned ADA-SCID gene therapy reveals ADA requirement in the hematopoietic system and clonal dominance of vector-marked clones
por: Uchiyama, Toru, et al.
Publicado: (2021)

Urogenital Abnormalities in Adenosine Deaminase Deficiency
por: Pajno, Roberta, et al.
Publicado: (2020)

Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency
por: Barzaghi, Federica, et al.
Publicado: (2022)

Review of Treatment for Adenosine Deaminase Deficiency (ADA) Severe Combined Immunodeficiency (SCID)
por: Secord, Elizabeth, et al.
Publicado: (2022)

ALPS-Like Phenotype Caused by ADA2 Deficiency Rescued by Allogeneic Hematopoietic Stem Cell Transplantation
por: Barzaghi, Federica, et al.
Publicado: (2019)

Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID)
por: Booth, Claire, et al.
Publicado: (2009)

Metabolite and thymocyte development defects in ADA-SCID mice receiving enzyme replacement therapy
por: Moretti, Federico A., et al.
Publicado: (2021)

PEGylated Recombinant Adenosine Deaminase Maintains Detoxification and Lymphocyte Counts in Patients with ADA-SCID
por: Dorsey, Morna J., et al.
Publicado: (2023)

Correction to: PEGylated Recombinant Adenosine Deaminase Maintains Detoxification and Lymphocyte Counts in Patients with ADA-SCID
por: Dorsey, Morna J., et al.
Publicado: (2023)

Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study
por: Ferrua, Francesca, et al.
Publicado: (2019)

Single Cell-Based Vector Tracing in Patients with ADA-SCID Treated with Stem Cell Gene Therapy
por: Igarashi, Yuka, et al.
Publicado: (2017)

Author Correction: Metabolite and thymocyte development defects in ADA-SCID mice receiving enzyme replacement therapy
por: Moretti, Federico A., et al.
Publicado: (2021)

Lentiviral gene therapy corrects platelet phenotype and function in patients with Wiskott-Aldrich syndrome
por: Sereni, Lucia, et al.
Publicado: (2019)

Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access
por: Fumagalli, Francesca, et al.
Publicado: (2022)

Gene Therapy for Adenosine Deaminase Deficiency: A Comprehensive Evaluation of Short- and Medium-Term Safety
por: Cicalese, Maria Pia, et al.
Publicado: (2018)

Primary Immunodeficiencies and Oncological Risk: The Experience of the Children's Hospital of Brescia
por: Maffeis, Marianna, et al.
Publicado: (2019)

Pioglitazone as a novel therapeutic approach in chronic granulomatous disease
por: Migliavacca, Maddalena, et al.
Publicado: (2016)

Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I
por: Penati, Rachele, et al.
Publicado: (2017)

Gene delivery using AAV8 in vivo for disease stabilization in a bimodal gene therapy approach for the treatment of ADA-deficient SCID
por: Carbonaro-Sarracino, Denise A., et al.
Publicado: (2021)

Monogenic polyarteritis: the lesson of ADA2 deficiency
por: Caorsi, Roberta, et al.
Publicado: (2016)

Hematopoietic reconstitution dynamics of mobilized- and bone marrow-derived human hematopoietic stem cells after gene therapy
por: Scala, Serena, et al.
Publicado: (2023)

Ada Lovelace
por: Jeapes, Ben, et al.
Publicado: (2019)

Ada Lovelace
por: Jeapes, Ben, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6mjp922jd69eqi9d4jvbv11noq